Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial. Cohen JA, Cutter GR, Fischer JS, Goodman AD, Heidenreich FR, Jak AJ, Kniker JE, Kooijmans MF, Lull JM, Sandrock AW, et al. Arch Neurol. 2001 Jun; 58(6):961-7. PMID: 11405811. Abstract CommentRecommendBookmarkWatch